Corneal inlay proves safe, effective and reversible option for presbyopes

Article

The KAMRA inlay (AcuFocus) is an effective, safe and reversible technique for the long-term surgical treatment of presbyopia.

The KAMRA inlay (AcuFocus) is an effective, safe and reversible technique for the long-term surgical treatment of presbyopia, states a 4-year follow-up study featured in the Journal of Cataract and Refractive Surgery.

Dr O.F. Yilmaz et al., Beyoğlu Eye Training and Research Hospital, Istanbul, Turkey, developed a clinical trial including 39 presbyopic phakic patients aged 45 to 60 years. Patients had an initial uncorrected near visual acuity (UNVA) of 20/40 or worse, this was correctable to 20/25 or better at distance.

After the LASIK flap was created or relifted the KAMRA inlay was implanted on the stromal bed and centred on the presurgical position of the first Purkinje reflex. Distance and near vision and the complication rate were measured.

It was found that 5 patients experienced cataract progression, 2 had a change in refractive status and there were no severe corneal complications or intraoperative complications during cataract extraction.

At a mean final UNVA of 20/20 all patients demonstrated an improvement in UNVA of 2 lines or more- with minimum loss in distance vision. In all eyes uncorrected distance acuity was 20/40 or better and it was recorded that 96% of patients could read J3 or better.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.